Frank Posnanski appointed as new CFO
PULSION’s Management Board trio complete again
The 41 year-old Frank Posnanski succeeds Stefan Land who left the company last year. Mr. Posnanski was previously divisional head of controlling with Kabel BW and, before that, head of controlling for Europe with the industrial company, Johnson Electrics, based in Hong Kong and Switzerland.
"PULSION forecasts a sale revenue growth of at least 20% and an EBIT margin of at least 15% for 2008. With the Management Board complete again, we look forward to the future with great optimism", stated Bradley Gould, Chairman of the Management Board of PULSION Medical Systems AG.
PULSION Medical Systems SE
PULSION Medical Systems AG, founded in 1990, has become one of the leading specialists for intelligent medical diagnosis and therapy management systems and has been listed on the Stock Exchange in Frankfurt since 2001. The repeated development of innovative product lines in the medtech field is the basis for creation and expansion of the attractive disposable business with sterile products and pharmaceuticals. The business unit PULSION Critical Care covering intensive care medicine, perioperative medicine and emergency medicine focuses on the management of cardiovascular and organ functions of critically ill patients. Products and activities of the business unit PULSION Pharma are directed at the diagnosis and therapy management of organ and tissue perfusion in ophthalmology, surgery and hepatology. PULSION products are marketed worldwide via own sales channels or secondary distribution. All products are certified with the CE mark which is basis for marketing in the EU and some other countries. The US-American FDA approval and the Japanese market approval have been issued for selected product lines. Further information about PULSION is available at www.pulsion.com.